These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Weakly coupled hyperbolic systems modeling the circulation of FeLV in structured feline populations. Fitzgibbon WE; Langlais M Math Biosci; 2000 May; 165(1):79-95. PubMed ID: 10804261 [TBL] [Abstract][Full Text] [Related]
3. Feline leukaemia virus: a review of immunity and vaccination. Sparkes AH J Small Anim Pract; 1997 May; 38(5):187-94. PubMed ID: 9179815 [TBL] [Abstract][Full Text] [Related]
4. Thoughts on retroviruses. Romatowski J J Am Vet Med Assoc; 1995 Jun; 206(11):1672. PubMed ID: 7782231 [No Abstract] [Full Text] [Related]
5. Cryptosporidium in cats--additional evidence for C. felis. Morgan UM; Sargent KD; Elliot A; Thompson RC Vet J; 1998 Sep; 156(2):159-61. PubMed ID: 9805485 [No Abstract] [Full Text] [Related]
7. Overexpression of feline tripartite motif-containing 25 interferes with the late stage of feline leukemia virus replication. Koba R; Oguma K; Sentsui H Virus Res; 2015 Jun; 204():88-94. PubMed ID: 25913257 [TBL] [Abstract][Full Text] [Related]
8. Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine. Harbour DA; Gunn-Moore DA; Gruffydd-Jones TJ; Caney SM; Bradshaw J; Jarrett O; Wiseman A Vaccine; 2002 Jul; 20(23-24):2866-72. PubMed ID: 12126896 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines. Poulet H; Thibault JC; Masias A Clin Vaccine Immunol; 2015 Dec; 22(12):1294-5. PubMed ID: 26604264 [No Abstract] [Full Text] [Related]
10. Reply to "Immunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines". Patel M; Carritt K; Lane J; Jayappa H; Stahl M; Bourgeois M Clin Vaccine Immunol; 2015 Dec; 22(12):1296-7. PubMed ID: 26604265 [No Abstract] [Full Text] [Related]
11. Evaluation of feline leukemia virus vaccines. Legendre AM J Am Vet Med Assoc; 1994 Jul; 205(1):28. PubMed ID: 7928542 [No Abstract] [Full Text] [Related]
12. Recombinant feline leukemia virus (FeLV) variants establish a limited infection with altered cell tropism in specific-pathogen-free cats in the absence of FeLV subgroup A helper virus. Bechtel MK; Hayes KA; Mathes LE; Pandey R; Stromberg PC; Roy-Burman P Vet Pathol; 1999 Mar; 36(2):91-9. PubMed ID: 10098636 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a saliva test kit for feline leukemia virus antigen. Babyak SD; Groves MG; Dimski DS; Taboada J J Am Anim Hosp Assoc; 1996; 32(5):397-400. PubMed ID: 8875354 [TBL] [Abstract][Full Text] [Related]
15. FeLV and FIV in a cat population. Brown R Vet Rec; 2007 Sep; 161(11):396. PubMed ID: 17873276 [No Abstract] [Full Text] [Related]
16. The occurrence of feline leukaemia virus neutralizing antibodies in cats. Russell PH; Jarrett O Int J Cancer; 1978 Sep; 22(3):351-7. PubMed ID: 212375 [No Abstract] [Full Text] [Related]
17. Fecal shedding of infectious feline leukemia virus and its nucleic acids: a transmission potential. Gomes-Keller MA; Gönczi E; Grenacher B; Tandon R; Hofman-Lehmann R; Lutz H Vet Microbiol; 2009 Mar; 134(3-4):208-17. PubMed ID: 18842363 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of diethylcarbamazine and 3'-azido-3'-deoxythymidine on feline leukemia virus lymphoma formation. Nelson P; Sellon R; Novotney C; Devera C; Davidian M; English R; Tompkins M; Tompkins W Vet Immunol Immunopathol; 1995 May; 46(1-2):181-94. PubMed ID: 7618257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]